Bisdemethoxycurcumin Inhibits Hepatocellular Carcinoma Proliferation Through Akt Inactivation via CYLD-Mediated Deubiquitination
Chengjiang Qiu,1 Kairui Liu,1 Sheng Zhang,1 Simin Gao,2 Weirun Chen,1 Dateng Li,3 Youxing Huang1 1Department of Abdominal Surgery, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, People’s Republic of China; 2Department of Breast Su...
Saved in:
Main Authors: | Qiu C (Author), Liu K (Author), Zhang S (Author), Gao S (Author), Chen W (Author), Li D (Author), Huang Y (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2020-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Curcumin, demethoxycurcumin, and bisdemethoxycurcumin induced caspase-dependent and -independent apoptosis via Smad or Akt signaling pathways in HOS cells
by: Cheng Huang, et al.
Published: (2020) -
CYLD expression in endometrial carcinoma and correlation with clinicohistopathological parameters
by: Vasiliki Papadatou, et al.
Published: (2022) -
IKK-mediated CYLD phosphorylation and cellular redox activity
by: Adnan Erol
Published: (2022) -
CYLD in health and disease
by: José L. Marín-Rubio, et al.
Published: (2023) -
Isorhamnetin Inhibits Human Gallbladder Cancer Cell Proliferation and Metastasis via PI3K/AKT Signaling Pathway Inactivation
by: Tianyu Zhai, et al.
Published: (2021)